VIKING GLOBAL PERFORMANCE LLC
CIK: 0001132625
Associated companies
Transaction History
| ROIV | ▼ Sell | Open Market | 110,756 | $1.1M | 6/22/2023 | View on chart |
| ROIV | ▼ Sell | Open Market | 5,427,043 | $53.7M | 6/22/2023 | View on chart |
| ROIV | ▼ Sell | Open Market | 5,236,006 | $51.8M | 6/22/2023 | View on chart |
| ROIV | ▼ Sell | Open Market | 2,226,195 | $22.0M | 6/22/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roivant Sciences receives downgrades from Wolfe Research and analyst
Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.
Roivant Sciences receives downgrades from Wolfe Research and analyst. Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.